Skip to main content
Journal of Patient-Reported Outcomes

Table 5 Interscale correlation of EORTC QLQ-C30

From: Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients

 

GS

PF

RF

EF

CF

SF

F

NV

P

DY

I

AL

C

DI

FD

GS

1

0.384*

0.493*

0.561*

0.364*

0.436*

 − 0.313*

 − 0.297*

 − 0.427*

 − 0.139+

 − 0.408*

 − 0.454*

 − 0.182*

 − 0.038

 − 0.429*

PF

0.384*

1

0.660*

0.472*

0.427*

0.631*

 − 0.217*

 − 0.208*

 − 0.370*

 − 0.207*

 − 0.690*

 − 0.409*

 − 0.221*

 − 0.065

 − 0.324*

RF

0.493*

0.660*

1

0.461*

0.471*

0.680*

 − 0.326*

 − 0.322*

 − 0.518*

 − 0.265*

 − 0.641*

 − 0.486*

 − 0.165*

 − 0.172*

 − 0.355*

EF

0.561*

0.472*

0.461*

1

0.440*

0.487*

 − 0.435*

 − 0.370*

 − 0.505*

 − 0.264*

 − 0.422*

 − 0.547*

 − 0.166*

 − 0.062

 − 0.281*

CF

0.364*

0.427*

0.471*

0.440*

1

0.466*

 − 0.200*

 − 0.229*

 − 0.332*

 − 0.277*

 − 0.498*

 − 0.257*

 − 0.275*

 − 0.098

 − 0.213*

SF

0.436*

0.631*

0.680*

0.487*

0.466*

1

 − 0.265*

 − 0.294*

 − 0.381*

 − 0.111*

 − 0.589*

 − 0.370*

 − 0.201*

 − 0.121

 − 0.357*

F

 − 0.313*

 − 0.217*

 − 0.326*

 − 0.435*

 − 0.200*

 − 0.265*

1

0.399*

0.602*

0.248*

0.335*

0.412*

0.152+

0.132+

0.230*

NV

 − 0.297*

 − 0.208*

 − 0.322*

 − 0.327*

 − 0.229*

 − 0.294*

0.399*

1

0.326*

0.134+

0.259*

0.382*

0.471*

0.201*

0.241*

P

 − 0.427*

 − 0.370*

 − 0.518*

 − 0.505*

 − 0.332*

 − 0.381*

0.602*

0.326*

1

0.285*

0.426*

0.508*

0.215*

0.101

0.277*

DY

 − 0.139+

 − 0.207*

 − 0.265*

 − 0.264*

 − 0.277*

 − 0.111

0.248*

0.134+

0.285*

1

0.171*

0.248*

0.165*

0.267*

0.155+

I

 − 0.408*

 − 0.690*

 − 0.641*

 − 0.422*

 − 0.498*

 − 0.589*

0.335*

0.259*

0.426*

0.171*

1

0.350*

0.171*

0.096

0.367*

AL

 − 0.454*

 − 0.409*

 − 0.486*

 − 0.547*

 − 0.257*

 − 0.370*

0.412*

0.382*

0.508*

0.248*

0.350*

1

0.174*

0.214*

0.296*

C

 − 0.182*

 − 0.221*

 − 0.165*

 − 0.166*

 − 0.275*

 − 0.201*

0.152+

0.471*

0.215*

0.165*

0.171*

0.174*

1

0.075

0.147+

DI

 − 0.038

 − 0.061

 − 0.172*

 − 0.062

 − 0.098

 − 0.121

0.132+

0.201*

0.101

0.267*

0.096

0.214*

0.075

1

0.167*

FD

 − 0.429*

 − 324*

 − 0.355*

 − 0.281*

 − 0.213

 − 0.357*

0.230*

0.241*

0.277*

0.155+

0.367*

0.296*

0.147+

0.167*

1

  1. GS, global scale; PF, physical functioning; RF, role functioning; EF, emotional functioning; CF, cognitive functioning; SF, social functioning; F, fatigue; NV, nausea and vomiting; P, pain; DY, dyspnea; I, insomnia; AL, appetite loss; C, constipation; DI, diarrhea; FD, financial difficulties
  2. +Significant at p < 0.05
  3. *Significant at p < 0.01
Back to article page